Cancer Genetics, Inc. Financial Statements 2011-2024 | CGIX

Annual Financial Statements Cancer Genetics, Inc.

	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	-	8.02 M	6.82 M	41.3 M	34.1 M	26.9 M	71.7 M	78.4 M	-	-
Shares	-	1.93 M	910 K	689 K	529 K	343 K	315 K	156 K	-	-
Net Income	-8 M	-	-	-	-	-	-	-	-	-
Revenue	5.75 M	-	-	-	-	-	-	-	-	-
EBITDA	-8.02 M	-	-	-	-	-	-	-	-	-
Operating Expenses	10.6 M	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	6.6 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency